FDA inspection
LGM Pharma Solutions, LLC: FDA inspection ending Jan 31, 2020
FDA inspection 1120565 · No Action Indicated (NAI) · Irvine, CA
Key facts
| Inspection ID | 1120565 |
|---|---|
| Firm | LGM Pharma Solutions, LLC |
| FEI number | 3017140477 |
| Address | 17802 Gillette Ave |
| City | Irvine |
| State | CA |
| ZIP | 92614 |
| Country | United States |
| Fiscal year | 2020 |
| Inspection end date | Jan 31, 2020 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data